Pravastatin and the development of diabetes mellitus. Evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study
Comaschi, M.A.; Menozzi, F.
Italian Heart Journal. Supplement Official Journal of the Italian Federation of Cardiology 2(5): 556-558
2001
ISSN/ISBN: 1129-4728 PMID: 11388336 Document Number: 536383
Document emailed within 1 workday
Related Documents
Lim, P.O.; Yee, K.M. 1999: Overlap analysis of the West of Scotland coronary prevention study (WOSCOPS) Circulation 100(6): 686Lowe, G.; Rumley, A.; Norrie, J.; Ford, I.; Shepherd, J.; Cobbe, S.; Macfarlane, P.; Packard, C. 2000: Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study Thrombosis and Haemostasis 84(4): 553-558
Barringer, T.A. 1997: WOSCOPS. West of Scotland Coronary Prevention Group Lancet 349(9049): 432-433
Deerochanawong, C.; Serirat, S. 1995: Clinical evaluation of pravastatin in the treatment of type Ii hyperlipidemia in patients with non-insulin-dependent diabetes mellitus Journal of the Medical Association of Thailand 78(3): 113-118
Soonthornpun, S.; Rattarasarn, C.; Leelawattana, R.; Thamprasit, A. 1997: Effect of pravastatin in treatment of hypercholesterolemia in non-insulin-dependent diabetes patients Journal of the Medical Association of Thailand 80(1): 9-15
Crepaldi, G.; Baggio, G.; Arca, M.; Avellone, G.; Avogaro, P.; Bittolo Bon, G.; Bompiani, G.D.; Capurso, A.; Cattin, L.; D'Alŏ, G. 1991: Pravastatin vs gemfibrozil in the treatment of primary hypercholesterolemia. The Italian Multicenter Pravastatin Study I Archives of Internal Medicine 151(1): 146-152
Weir, R.D.; Dingwall-Fordyce, I. 1975: Diabetes mellitus in Scotland Health Bulletin 33(2): 90-92
Farouque, H.M.; O'Brien, R.C.; Meredith, I.T. 2000: Diabetes mellitus and coronary heart disease--from prevention to intervention: Part I Australian and New Zealand Journal of Medicine 30(3): 351-359
Samani, N.J.; de Bono, D.P. 1996: Prevention of coronary heart disease with pravastatin New England Journal of Medicine 334(20): 1333-1334; Author Reply 1334-1335
Santos, R.D.; Mansur, A.P.; Safi Júnior, J.; Giraldez, R.R.; Maranhão, R.C.; Pileggi, F.; Ramires, J.A. 1995: Comparative study of gemfibrozil versus pravastatin in the treatment of patients with coronary artery disease and low HDL cholesterol levels Arquivos Brasileiros de Cardiologia 65(2): 181-183
Yao, K.; Xu, B.; Gao, L.; Ge, J.-b. 2005: Pravastatin activates platelet nitric oxide synthase (NOS) in patients with type 2 diabetes mellitus and NOS activation is accompanied by serine phosphorylation Chinese Medical Journal 118(19): 1654-1657
Feskens, E.J. 1992: Role of nutrition in the development of type II diabetes mellitus and of glucose intolerance; possibilities for prevention Nederlands Tijdschrift Voor Geneeskunde 136(35): 1701-1706
Lobanova, L.A.; Ermolenko, R.I.; Mukhambetova, L.M. 1974: Effect of diabetes mellitus on sexual development of girls Voprosy Okhrany Materinstva i Detstva 19(2): 22-24
Xia, H.; He, R.; Chen, J. 1996: Protective effect of angiotensin coverting enzyme inhibitor on renal function in normotensive non-insulin dependent diabetes mellitus patients with early diabetic nephropathy and microalbuminuria Zhonghua Nei Ke Za Zhi 35(8): 533-536
Young, I.; Flowers, P.; McDaid, L.M. 2015: Key factors in the acceptability of treatment as prevention (TasP) in Scotland: a qualitative study with communities affected by HIV Sexually Transmitted Infections 91(4): 269-274
Slezáková, J. 1977: Effect of diabetes mellitus on the growth and development characteristics of affected children Ceskoslovenska Pediatrie 32(5): 257-259
Nunoi, K.; Fukui, T.; Sato, Y.; Sakuragi, R. 2005: Management of IGT education program at a hospital and its primary prevention effect on diabetes mellitus Nihon Rinsho. Japanese Journal of Clinical Medicine 63 Suppl. 2: 582-587
Gorus, F.K. 1996: The importance of diabetes registries and clinical biology for the study and treatment of type 1 (insulin-dependent) diabetes mellitus Verhandelingen - Koninklijke Academie Voor Geneeskunde van Belgie 58(5): 539-586
Wang, H.-p.; Hou, Z.-y.; Meng, Q.-y. 2013: A comparative study on medical expenditure for diabetes mellitus and non-diabetes mellitus in 9 provinces of China, between 2000 and 2009 Zhonghua Liu Xing Bing Xue Za Zhi 34(9): 911-913
Estopiñán García, V.; Fortea Gimeno, L. 1992: Perspectives of immunosuppressive treatment for the prevention of diabetes mellitus type I Anales de Medicina Interna 9(10): 471-472